Lovastatin Tablet
Product Images NDC 68788-9668

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Lovastatin (NDC 68788-9668). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

20mg 100ct

This is a description of Lovastatin Tablets, USP 20mg, a generic medication for Mevacor. The medication is manufactured by Carlsbad Technology, Inc based in Carlsbad, CA, and distributed by Preferred Pharmaceuticals, Inc. The package size and expiration date are not available, but each tablet contains Lovastatin, USP 20mg. There are directions in English that indicate taking tablet(s) every few hours with a warning that federal law prohibits the transfer of this drug to anyone other than the individual for whom it was prescribed. However, there are several sections of the text that are not readable.*

FDA Label Image

40mg 100ct

This is a description of Lovastatin Tablets, USP 40mg, which is a generic medication for Mevacor. The tablets are manufactured by Carlsbad Technology Inc. The package size, expiration date, lot and batch numbers are provided on the packaging. There are also cautionary notes to prevent the transfer of the medication to anyone other than the prescribed patient due to federal law restrictions. The rest of the text contains illegible characters and cannot be evaluated.*

FDA Label Image

Structural Formula (Lov00 0004 01)

FDA Label Image

Table I (Lov00 0004 02)

FDA Label Image

Figure 1 (Lov00 0004 03)

This appears to be a graph or chart, labeled as "Figure 1". The title of the graph is "Proportion of Participants Without Event", and it appears to be related to "Acute Major Coronary Events" as the primary endpoint. The x-axis is labeled as "Years of Follow-up". No additional information can be identified from this text.*

FDA Label Image

Table Vii (Lov00 0005 04)

This is a table that provides drug interactions associated with an increased risk of myopathy/rhabdomyolysis. The table includes prescribing recommendations for different medications. Strong CYP3A4 inhibitors such as ketoconazole, HIV protease inhibitors like boceprevir and telaprevic, Nefazodone, cobicistat-containing products are contraindicated with lovastatin. Gemfibrozil should be avoided with lovastatin. Cyclosporine, danazol, diltiazem, dronedarone should not exceed specific daily doses of lovastatin. Lastly, grapefruit juice should be avoided.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.